Asthma Patients Treated Safely with Salmeterol-Fluticasone Combo
An FDA-mandated study finds use of LABA plus ICS in a single inhaler noninferior to ICS alone with regard to serious asthma outcomes. (Source: ConsultantLive)
Source: ConsultantLive - May 9, 2016 Category: Internal Medicine Authors: Mark L. Fuerst Tags: Asthma Source Type: news
An Unusual Cause of Laryngotracheobronchitis
We present a case of pseudomembranous cryptococcal laryngotracheobronchitis in an 80-year-old woman with a history of intractable cough with production of long sputum strings and severe dysphonia. Her main risk factor was considered to be the use of high-dose inhaled fluticasone, given for severe mixed asthma/chronic obstructive pulmonary disease (COPD). This is an unusual presentation of pulmonary cryptococcal disease, which commonly presents as parenchymal disease. We also present a review of the published case reports of endobronchial and laryngeal cryptococcal disease. (Source: Clinical Microbiology Newsletter)
Source: Clinical Microbiology Newsletter - May 5, 2016 Category: Microbiology Authors: Vidthiya Menon, H.E. Jo, P. Corte, A.S. Lee, A.C. Wignall, H.K. Reddel Source Type: news
No Mortality Benefit in COPD With Fluticasone Furoate/Vilanterol No Mortality Benefit in COPD With Fluticasone Furoate/Vilanterol
Patients with COPD and cardiovascular disease risk receiving an inhaled corticosteroid, a long-acting beta agonist, or both showed no difference from placebo in all-cause mortality. Medscape Medical News (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - May 4, 2016 Category: Allergy & Immunology Tags: Pulmonary Medicine News Source Type: news
Humana accidentally told thousands of people their drugs weren’t FDA approved
There are lots of sniffling, stuffy-nosed allergy sufferers this time of year.
There was no relief for some Humana Inc. (NYSE: HUM) customers in Texas, who were told a generic allergy medication wasn't covered by their insurance and that they'd have to pay full price, according to the Austin American-Statesman.
Humana said the drug — a generic version of the allergy drug Flonase, manufactured by GlaxoSmithKline — wasn't approved by the U.S. Food and Drug Administration. And the Louisville-based… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - April 12, 2016 Category: Pharmaceuticals Authors: Baylee Pulliam Source Type: news
Is It A Cold Or Allergy? How You Can Tell
BOSTON (CBS) — Signs of spring are in the air but that’s not something you have to tell allergy sufferers.
This season has arrived a bit earlier than usual.
WBZ-TV’s Dr. Mallika Marshall has been seeing patients in her clinic for the past couple of weeks who are already complaining about their allergies.
Much of that is due to warmer temperatures. In fact, some areas are seeing tree pollen a month earlier than usual. Grass and flower pollen will soon follow.
Since it is still cold and flu season, how can you tell what is bothering you?
Dr. Marshall says there is some overlap in symptoms like nasal congest...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - March 24, 2016 Category: Consumer Health News Authors: torrancelatham Tags: Health Local News Seen On WBZ-TV Syndicated Local Watch Listen Allergies Cold Dr. Mallika Marshall Source Type: news
Fluticasone-Salmeterol Noninferior to Fluticasone for Serious Asthma Events (FREE)
By Kelly Young
Edited by Susan Sadoughi, MD, and André Sofair, MD, MPH
Fluticasone plus salmeterol is noninferior to fluticasone monotherapy in the risk for serious asthma-related events, finds an industry-conducted study in the New England Journal of … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - March 7, 2016 Category: Primary Care Source Type: news
AAAAI: Risks comparable in adult asthma patients given fluticasone and salmeterol plus fluticasone combo
LOS ANGELES – Fluticasone-salmeterol inhalers (Advair) are as safe as and more effective than fluticasone monotherapy inhalers are for patients with moderate to severe asthma, according to a large,... (Source: Pediatric News)
Source: Pediatric News - March 6, 2016 Category: Journals (General) Source Type: news
AAAAI: Risks comparable in adult asthma patients given fluticasone and salmeterol plus fluticasone combo
LOS ANGELES – Fluticasone-salmeterol inhalers (Advair) are as safe as and more effective than fluticasone monotherapy inhalers are for patients with moderate to severe asthma, according to a large,... (Source: Family Practice News)
Source: Family Practice News - March 6, 2016 Category: Primary Care Source Type: news
5 Ways To Stop A Nagging Cough
SPECIAL FROM Holiday shopping. Holiday parties. Airplanes. It seems like wherever you go this time of year, you’re bound to find someone coughing on you. Ick. Next thing you know, you’re coughing, too. How to stop your nagging cough? We asked the experts. “Coughing is one of the most common reasons people visit their health care provider,” says Rachel Taliercio, D.O, a pulmonologist with the Respiratory Institute at the Cleveland Clinic. And there are a variety of diseases that cause people to cough. How you treat that cough depends on what’s causing it in the first place. That said, there a...
Source: Healthy Living - The Huffington Post - December 24, 2015 Category: Consumer Health News Source Type: news
New Sandoz patient-centric inhaler now available to treat adults with COPD
Novel inhaler approved for adults with chronic obstructive pulmonary disease (COPD) (Source: Pharmacy Europe)
Source: Pharmacy Europe - November 24, 2015 Category: Drugs & Pharmacology Authors: Annabel De Coster Tags: *** Editor's Pick Practical therapeutics Respiratory Patient care AirFluSal copd fluticasone propionate Forspiro inhaler Latest News salmeterol Seretide Accuhaler treatment adherence Source Type: news
fluticasone propionate (Cutivate)
Title: fluticasone propionate (Cutivate)Category: MedicationsCreated: 3/2/2005 12:00:00 AMLast Editorial Review: 9/15/2015 12:00:00 AM (Source: MedicineNet Skin General)
Source: MedicineNet Skin General - September 15, 2015 Category: Dermatology Source Type: news
GSK and Theravance report initial results of SUMMIT COPD survival study
GlaxoSmithKline (GSK) and Theravance have reported the initial results for Relvar / Breo Ellipta 100mcg / 25mcg (fluticasone furoate 'FF' / vilanterol) as part of the study to understand mortality and morbidity in chronic obstructive pulmonary diseas… (Source: Drug Development Technology)
Source: Drug Development Technology - September 8, 2015 Category: Pharmaceuticals Source Type: news
fluticasone furoate nasal spray (Veramyst)
Title: fluticasone furoate nasal spray (Veramyst)Category: MedicationsCreated: 3/2/2005 12:00:00 AMLast Editorial Review: 8/28/2015 12:00:00 AM (Source: MedicineNet Medications General)
Source: MedicineNet Medications General - August 28, 2015 Category: Drugs & Pharmacology Source Type: news
fluticasone furoate nasal spray (Veramyst)
Title: fluticasone furoate nasal spray (Veramyst)Category: MedicationsCreated: 3/2/2005 12:00:00 AMLast Editorial Review: 8/28/2015 12:00:00 AM (Source: MedicineNet Allergies General)
Source: MedicineNet Allergies General - August 28, 2015 Category: Allergy & Immunology Source Type: news
Canada Approves Breo Ellipta for Adults With AsthmaCanada Approves Breo Ellipta for Adults With Asthma
The combination of fluticasone furoate and vilanterol was already indicated in Canada for chronic obstructive pulmonary disease. International Approvals (Source: Medscape FamilyMedicine Headlines)
Source: Medscape FamilyMedicine Headlines - August 11, 2015 Category: Primary Care Tags: Pulmonary Medicine News Alert Source Type: news
